マーケットレポート詳細

オートインジェクター：世界市場2026年予測

Autoinjectors: Global Markets

出版元：BCC Research　 出版元について
発行年：2021年11月
定価 ：Single User License(1名様ライセンス)US$5,500(米国ドル)/2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算（お見積り日TTSレート）となります。
納品形態：PDF by Email
当調査レポートは英文123ページになります。
商品コード：BCC334

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

オートインジェクターの世界市場規模は2021年に415億ドル、2026年には852億ドルに拡大する見通しです。

オートインジェクターは、自己注射用に使われるペン型の定量注射器で、アナフィラキシーや多発性硬化症、および関節リウマチなどの治療においては、徐々に標準的な仕様になりつつあります。オートインジェクターの多くはスプリング仕様で、注射方法はシンプルなものです。メーカー各社はユーザー視点のアプローチで、より簡単な使用方法の工夫や、自己注射に伴う不安を緩和する方向に注力しています。

当レポートでは、オートインジェクターの市場/技術的背景、各種セグメント別市場分析(製品タイプ別、投与経路別、治療別、エンドユーザー別、国地域別)、COVID-19の影響、市場ダイナミクス、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

◆イントロダクション

・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆市場および技術的背景
・市場の進化

◆COVID-19の影響

・健康製品における消費トレンドの変化

◆市場ダイナミクス

・市場の障壁

◆オートインジェクター市場、製品タイプ別

・ディスポーザブルオートインジェクター
・再使用可能オートインジェクター
※市場予測データ-2026年掲載
※製品タイプ別に地域別の細分化データ掲載

◆オートインジェクター市場、投与経路別

・筋肉内注射
・皮下注射
※市場予測データ-2026年掲載
※投与経路別に地域別の細分化データ掲載

◆オートインジェクター市場、治療別

・アナフィラキシー
・関節リウマチ
・多発性硬化症
・糖尿病
・その他
※市場予測データ-2026年掲載
※治療別に地域別の細分化データ掲載

◆オートインジェクター市場、エンドユーザー別

・在宅治療
・病院、クリニック
・外来治療
※市場予測データ-2026年掲載
※エンドユーザー別に地域別の細分化データ掲載

◆オートインジェクター市場、地域別

北米
・米国、カナダ
欧州
・ドイツ、英国、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※地域別に全セグメント別の細分化データ掲載、詳細は目次参照

◆規制シナリオ

医療機器の定義及び分類
主要国地域別の規制
・米国
・欧州
・北米
・中南米
・アジア太平洋
今後の規制トレンド

◆競合状況

・企業ランキング

◆企業プロフィール

・ABBVIE INC.
・AMGEN INC.
・ANTARES PHARMA INC.
・BECTON, DICKINSON AND CO.
・ELI LILLY AND CO.
・GLAXOSMITHKLINE PLC
・JOHNSON & JOHNSON
・MERCK KGAA
・SHL MEDICAL AG
・TEVA PHARMACEUTICAL INDUSTRIES LTD.
・YPSOMED

（全123頁）


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Introduction
Market Evolution

Chapter 4 Impact of COVID-19 Pandemic

Impact of COVID-19 on Markets
Changes in Consumption Trends for Health-Related Products

Chapter 5 Market Dynamics

Overview

Market Restraints

Chapter 6 Market Breakdown by Product Type

Market for Autoinjectors by Product Type
Disposable Autoinjectors

Reusable Autoinjectors

Chapter 7 Market Breakdown by Route of Administration

Market for Autoinjectors by Route of Administration
Intramuscular

Subcutaneous

Chapter 8 Market Breakdown by Therapy

Anaphylaxis

Rheumatoid Arthritis

Multiple Sclerosis

Diabetes

Others

Chapter 9 Market Breakdown by End User

Home Care Settings

Hospitals and Clinics

Ambulatory Care Settings

Chapter 10 Market Breakdown by Region

North America

Europe

Asia-Pacific

Latin America
Middle East and Africa

Chapter 11 Regulatory Scenarios

Medical Device Definition and Classification
Regulations in the U.S.

European Regulations
Regulation in North American Countries

Regulation in Latin America
Regulation in Asia-Pacific
Future Regulatory Trends

Chapter 12 Competitive Landscape

Overview
Company Rankings

Chapter 13 Company Profiles

ABBVIE INC.
AMGEN INC.
ANTARES PHARMA INC.
BECTON, DICKINSON AND CO.
ELI LILLY AND CO.
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
MERCK KGAA
SHL MEDICAL AG
TEVA PHARMACEUTICAL INDUSTRIES LTD.
YPSOMED

List of Tables

Summary Table : Global Market for Autoinjectors, by Region, Through 2026
Table 1 : Global Market for Autoinjectors, by Product Type, Through 2026
Table 2 : Global Market for Disposable Autoinjectors, by Region, Through 2026
Table 3 : Global Market for Reusable Autoinjectors, by Region, Through 2026
Table 4 : Global Market for Autoinjectors, by Route of Administration, Through 2026
Table 5 : Global Market for Intramuscular Autoinjectors, by Region, Through 2026
Table 6 : Global Market for Subcutaneous Autoinjectors, by Region, Through 2026
Table 7 : Global Market for Autoinjectors, by Therapy, Through 2026
Table 8 : Global Market for Autoinjectors for Anaphylaxis Therapy, by Region, Through 2026
Table 9 : Global Market for Autoinjectors for Rheumatoid Arthritis Therapy, by Region, Through 2026
Table 10 : Global Market for Autoinjectors for Multiple Sclerosis Therapy, by Region, Through 2026
Table 11 : Global Market for Autoinjectors for Diabetes Therapy, by Region, Through 2026
Table 12 : Global Market for Autoinjectors for Other Therapies, by Region, Through 2026
Table 13 : Global Market for Autoinjectors, by End User Setting, Through 2026
Table 14 : Global Market for Autoinjectors Used in Home Care Settings, by Region, Through 2026
Table 15 : Global Market for Autoinjectors Used in Hospitals and Clinics, by Region, Through 2026
Table 16 : Global Market for Injectors Used in Ambulatory Care Settings, by Region, Through 2026
Table 17 : Global Market for Autoinjectors, by Region, Through 2026
Table 18 : North American Market for Autoinjectors, by Product Type, Through 2026
Table 19 : North American Market for Autoinjectors, by Route of Administration, Through 2026
Table 20 : North American Market for Autoinjectors, by Therapy, Through 2026
Table 21 : North American Market for Autoinjectors, by End User Setting, Through 2026
Table 22 : North American Market for Autoinjectors,  Through 2026
Table 23 : European Market for Autoinjectors, by Product Type, Through 2026
Table 24 : European Market for Autoinjectors, by Route of Administration, Through 2026
Table 25 : European Market for Autoinjectors, by Therapy, Through 2026
Table 26 : European Market for Autoinjectors, by End User Setting, Through 2026
Table 27 : European Market for Autoinjectors, by Country, Through 2026
Table 28 : Asia-Pacific Market for Autoinjectors, by Product Type, Through 2026
Table 29 : Asia-Pacific Market for Autoinjectors, by Route of Administration, Through 2026
Table 30 : Asia-Pacific Market for Autoinjectors, by Therapy, Through 2026
Table 31 : Asia-Pacific Market for Autoinjectors, by End User Setting, Through 2026
Table 32 : Asia-Pacific Market for Autoinjectors, by Country, Through 2026
Table 33 : Latin American Market for Autoinjectors, by Product Type, Through 2026
Table 34 : Latin American Market for Autoinjectors, by Route of Administration, Through 2026
Table 35 : Latin American Market for Autoinjectors, by Therapy, Through 2026
Table 36 : Latin American Market for Autoinjectors, by End User Setting, Through 2026
Table 37 : Middle Eastern and African Market for Autoinjectors, by Product Type, Through 2026
Table 38 : Middle Eastern and African Market for Autoinjectors, by Route of Administration, Through 2026
Table 39 : Middle Eastern and African Market for Autoinjectors, by Therapy, Through 2026
Table 40 : Middle Eastern and African Market for Autoinjectors, by End User Setting, Through 2026
Table 41 : Class I and Class II Exempt Devices
Table 42 : Differences Between U.S. and European Government Regulations for Medical Devices
Table 43 : Regulation in Selected Asia-Pacific Countries
Table 44 : Top Five Companies in the Autoinjector Market, 2020
Table 45 : Recent Developments in the Autoinjector Market, 2018 to 2021
Table 46 : AbbVie: Product Portfolio
Table 47 : Amgen: Product Portfolio
Table 48 : Amgen: Recent Developments, 2021
Table 49 : Antares Pharma: Product Portfolio
Table 50 : Antares Pharma: Recent Developments
Table 51 : BD: Product Portfolio
Table 52 : BD: Recent Developments
Table 53 : Eli Lilly: Product Portfolio
Table 54 : Eli Lilly: Recent Developments
Table 55 : GlaxoSmithKline PLC: Products
Table 56 : GlaxoSmithKline PLC: Recent Developments
Table 57 : Johnson & Johnson: Product Portfolio
Table 58 : Johnson & Johnson: Recent Developments
Table 59 : Merck KGaA: Product Portfolio
Table 60 : SHL Medical AG: Product Portfolio
Table 61 : SHL Medical Ag: Recent Developments
Table 62 : Teva Pharmaceutical: Product Portfolio
Table 63 : Teva Pharmaceutical: Recent Developments
Table 64 : Ypsomed: Product Portfolio
Table 65 : Ypsomed: Recent Developments

List of Figures

Summary Figure A : Global Market for Autoinjectors, by Region, 2019-2026
Summary Figure B : Global Market Shares for Autoinjectors, by Region, 2020
Figure 1 : Global Market Share for Autoinjectors, by Product Type, 2020
Figure 2 : Global Market for Autoinjectors, by Product Type, 2019-2026
Figure 3 : Global Market for Disposable Autoinjectors, 2019-2026
Figure 4 : Global Market for Reusable Autoinjectors, 2019-2026
Figure 5 : Global Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 6 : Global Market for Autoinjectors, by Route of Administration, 2019-2026
Figure 7 : Global Market for Intramuscular Autoinjectors, 2019-2026
Figure 8 : Global Market for Subcutaneous Autoinjectors, 2019-2026
Figure 9 : Global Market Shares of Autoinjectors, by Therapy, 2020
Figure 10 : Global Market for Autoinjectors, by Therapy, 2019-2026
Figure 11 : Global Market for Autoinjectors for Anaphylaxis Therapy, 2019-2026
Figure 12 : Global Market for Autoinjectors for Rheumatoid Arthritis Therapy, 2019-2026
Figure 13 : Global Market for Autoinjectors for Multiple Sclerosis Therapy, 2019-2026
Figure 14 : Global Market for Autoinjectors for Diabetes Therapy, 2019-2026
Figure 15 : Global Market for Autoinjectors for Other Therapies, 2019-2026
Figure 16 : Global Market Shares of Autoinjectors, by End User Setting, 2020
Figure 17 : Global Market for Autoinjectors Used in Home Care Settings, 2019-2026
Figure 18 : Global Market for Autoinjectors Used in Home Care Settings, by Region, 2019-2026
Figure 19 : Global Market for Autoinjectors Used in Hospitals and Clinics, 2019-2026
Figure 20 : Global Market for Autoinjectors Used in Hospitals and Clinics, by Region, 2019-2026
Figure 21 : Global Market for Autoinjectors Used in Ambulatory Care Settings, 2019-2026
Figure 22 : Global Market for Autoinjectors Used in Ambulatory Care Settings, by Region, 2019-2026
Figure 23 : Global Market Shares of Autoinjectors, by Region, 2020
Figure 24 : North American Market Shares of Autoinjectors, by Product Type, 2020
Figure 25 : North American Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 26 : North American Market Shares of Autoinjectors, by Therapy, 2020
Figure 27 : North American Market Shares of Autoinjectors, by End User Setting, 2020
Figure 28 : North American Market Shares of Autoinjectors, by Country, 2020
Figure 29 : U.S. Market for Autoinjectors, 2019-2026
Figure 30 : Canadian Market for Autoinjectors, 2019-2026
Figure 31 : European Market Shares of Autoinjectors, by Product Type, 2020
Figure 32 : European Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 33 : European Market Shares of Autoinjectors, by Therapy, 2020
Figure 34 : European Market Shares of Autoinjectors, by End User Setting, 2020
Figure 35 : European Market Shares of Autoinjectors, by Country, 2020
Figure 36 : German Market for Autoinjectors, 2019-2026
Figure 37 : U.K. Market for Autoinjectors, 2019-2026
Figure 38 : French Market for Autoinjectors, 2019-2026
Figure 39 : Italian Market for Autoinjectors, 2019-2026
Figure 40 : Spanish Market for Autoinjectors, 2019-2026
Figure 41 : Rest of European Market for Autoinjectors, 2019-2026
Figure 42 : Asia-Pacific Market Shares of Autoinjectors, by Product Type, 2020
Figure 43 : Asia-Pacific Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 44 : Asia-Pacific Market Shares of Autoinjectors, by Therapy, 2020
Figure 45 : Asia-Pacific Market Shares of Autoinjectors, by End User Setting, 2020
Figure 46 : Asia-Pacific Market Shares of Autoinjectors, by Country, 2020
Figure 47 : Chinese Market for Autoinjectors, 2019-2026
Figure 48 : Japanese Market for Autoinjectors, 2019-2026
Figure 49 : India’s Market for Autoinjectors, 2019-2026
Figure 50 : Rest of Asia-Pacific Market for Autoinjectors, 2019-2026
Figure 51 : Latin American Market Shares of Autoinjectors, by Product Type, 2020
Figure 52 : Latin American Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 53 : Latin American Market Shares of Autoinjectors, by Therapy, 2020
Figure 54 : Latin American Market Shares of Autoinjectors, by End User Setting, 2020
Figure 55 : Middle Eastern and African Market Shares of Autoinjectors, by Product Type, 2020
Figure 56 : Middle Eastern and African Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 57 : Middle Eastern and African Market Shares of Autoinjectors, by Therapy, 2020
Figure 58 : Middle Eastern and African Market Shares of Autoinjectors, by End User Setting, 2020
Figure 59 : Marketing a Medical Device in the U.S.
Figure 60 : AbbVie: Annual Revenue, 2016-2020
Figure 61 : AbbVie: Revenue Share, by Region, 2020
Figure 62 : AbbVie: Revenue Share, by Business Unit, 2020
Figure 63 : Amgen: Annual Revenue, 2018–2020
Figure 64 : Amgen: Revenue Share, by Region, 2020
Figure 65 : Antares Pharma: Annual Revenue, 2018–2020
Figure 66 : Antares Pharma: Revenue Share, by Region, 2020
Figure 67 : BD: Annual Revenue, 2018–2020
Figure 68 : BD: Revenue Share, by Region, 2020
Figure 69 : BD: Revenue Share, by Business Segment, 2020
Figure 70 : Eli Lilly: Annual Revenue, 2017-2020
Figure 71 : Eli Lilly: Revenue Share, by Region, 2020
Figure 72 : Eli Lilly: Revenue Share, by Segment, 2020
Figure 73 : GlaxoSmithKline PLC: Annual Revenue, 2017-2020
Figure 74 : GlaxoSmithKline PLC: Revenue Share, by Business Segment, 2020
Figure 75 : GlaxoSmithKline PLC: Revenue Share, by Region, 2020
Figure 76 : Johnson & Johnson: Annual Revenue, 2016-2019
Figure 77 : Johnson & Johnson: Revenue Share, by Region, 2019
Figure 78 : Johnson & Johnson: Revenue Share, by Business Unit, 2019
Figure 79 : Merck KGaA: Annual Revenue, 2019-2020
Figure 80 : Merck KGaA: Revenue Share, by Region, 2020
Figure 81 : Merck KGaA: Revenue Share, by Business Segment, 2020
Figure 82 : Teva Pharmaceutical: Annual Revenue, 2017-2020
Figure 83 : Ypsomed: Annual Revenue, 2018–2020


△ 一番上に戻る